“We don’t need an #HIVvaccine because #PrEP is imperfect. We need one to end the epidemic, durably & decisively,” said Mitchell Warren. “Treatment and prevention take us far. A #vaccine gets us to the finish line.” #HVAD2025

avac.org/blog/introdu...

@iasociety.bsky.social @guscairns.bsky.social

HIV Prevention at a Crossroads: Why we still need an HIV vaccine Discusses the continued need for an HIV vaccine in the context of the expanding HIV prevention landscape and uncertain geopolitical environment. Panelists and audience members are invited to explore t...

Happening now: A critical conversation on why we still need an HIV vaccine. Panelists are unpacking the public health, equity, and geopolitical stakes.

Join: avac.org/event/hiv-pr...
Hosted by IAVI and @iasociety.bsky.social Global HIV Vaccine Enterprise. #HVAD2025 #HIVvaccine

📢 ICYMI, a new viewpoint in #JIAS and an #HVAD2025 webinar highlight progress in inducing broadly neutralizing antibodies (#bNAbs), a promising path forward in HIV prevention.

🔗 Read: onlinelibrary.wiley.com/doi/full/10....
🎧 Watch the webinar: avac.org/event/recent...

🌐 The IAS Global HIV Vaccine Enterprise promotes #HIV vaccine development by sharing knowledge, fostering collaboration, prioritizing #HIVvaccine R&D on the global health agenda, and supporting early-career African researchers and advocates.

Learn more now: zurl.co/mr7eY

#HVAD #HVAD2025

Atomic precision: Pioneering HIV vaccine triggers key immune response Scientists hail a new era of HIV vaccine design, as an experimental vaccine triggers the beginnings of a broadly protective antibody response in humans.

🌟 "In a step toward ending one of the world’s deadliest pandemics, researchers have shown that it’s possible to spark the beginnings of a broadly neutralising antibody response against #HIV – one of vaccinology’s greatest challenges." #HVAD #HVAD2025

“Status of #HIV vaccine development: progress & promise"

The Journal of the International AIDS Society has published a special #HIVVaccineAwarenessDay viewpoint, highlighting recent advancements!

📢 Read, share & join us in calling for greater investment in #HIV vaccine research!

#HVAD #HVAD2025

Welcome! You are invited to join a webinar: HIV prevention at a crossroads: why we still need an HIV vaccine. After registering, you will receive a confirmation email about joining the webinar. To mark HIV Vaccine Awareness Day 2025, the Global HIV Vaccine Enterprise of IAS – the International AIDS Society – and IAVI welcome the global HIV community to join for a discussion on the continued need for an HIV vaccine in the context of the expanding HIV prevention landscape and uncertain geopolitical environment. Panellists and audience members are invited to explore the potential public health impact of an HIV vaccine, including related socioeconomic and equity considerations. Participants will further reflect on the rising threat to vaccine science and why investments in HIV vaccine R&D remain a strategic priority in the global HIV response. By finalizing your registration, you agree with the IAS - International AIDS Society - privacy policy (https://www.iasociety.org/privacy-policy). The IAS will collect and process your personal data (first name, last name, e-mail address, country, job title, organization, profession) for (i) statistics on the results of this event (ii) sharing the recording and slides of this webinar (iii) informing you on IAS activities.

📅 Join us on Wednesday, 28 May at 15:00 CEST for our #webinar, “#HIV prevention at a crossroads: Why we still need an HIV vaccine”.

✅ Register today on #HVAD for this discussion & join the movement for a safe, effective & accessible HIV vaccine! #HVAD2025

💉🌍 It's almost #HIVVaccineAwarenessDay! Join @iasociety.bsky.social & Duke University's Human Vaccine Institute at 9:00am ET today for a webinar on the future of HIV vaccines! For more #HVAD2025 resources and webinars, visit, avac.org/hiv-vaccine-....

This #HVAD2025 comes as the US administration is dismantling #HIV research & demolishing the architecture of #globalhealth. The world runs the risk of reversing the strides made to end HIV. Read how advocacy and science must move forward, avac.org/blog/hvad2025

#HVAD2025